Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317214248> ?p ?o ?g. }
- W4317214248 endingPage "60" @default.
- W4317214248 startingPage "38" @default.
- W4317214248 abstract "Cancer as a disease possess quite complicated pathophysiological implications and is among the prominent causes of morbidity and mortality on global scales. Anti-cancer chemotherapy, surgery, and radiation therapy are some of the present-day conventional treatment options. However, these therapeutic paradigms own several retreats, including lack of specificity, non-targeted toxicological implications, inefficient drug delivery to targeted cells, and emergence of cancer resistance, ultimately causing ineffective cancer management. Owing to the advanced and better biophysical characteristic features and potentiality for the tailoring and customizations and in several fashions, nanotechnology can entirely transubstantiate the cancer identification and its managements. Additionally, nanotechnology also renders several answers to present-day mainstream limitations springing-up in anti-cancer therapeutics. Nanocarriers, owing to their outstanding physicochemical features including but not limited to their particle size, surface morphological features viz. shape etc., have been employed in nanomedicinal platforms for targeting various transcription factors leading to worthy pharmacological outcomes. This transcription targeting activates the wide array of cellular and molecular events like antioxidant enzyme-induction, apoptotic cell death, cell-cycle arrest etc. These outcomes are obtained after the activation or inactivation of several transcription factors and cellular pathways. Further, nanoformulations have been precisely calibrated and functionalized with peculiar targeting groups for improving their efficiency to deliver the drug-payload to specified and targeted cancerous cells and tissues. This review undertakes an extensive, across-the-board and all-inclusive approach consisting of various studies encompassing different types of tailored and customized nanoformulations and nanomaterials designed for targeting the transcription factors implicated in the process of carcinogenesis, tumor-maturation, growth and metastasis. Various transcription factors viz. nuclear factor kappa (NF-κB), signal transducer and activators of transcription (STAT), Cmyc and Twist-related protein 1 (TWIST1) along with several types of nanoparticles targeting these transcription factors have been summarized here. A section has also been dedicated to the different types of nanoparticles targeting the hypoxia inducing factors. Efforts have been made to summarize several other transcription factors implicated in various stages of cancer development, growth, progression and invasion, and their targeting with different kinds of nanomedicinal agents." @default.
- W4317214248 created "2023-01-18" @default.
- W4317214248 creator A5002473760 @default.
- W4317214248 creator A5036589842 @default.
- W4317214248 creator A5050167205 @default.
- W4317214248 creator A5057043467 @default.
- W4317214248 creator A5067492664 @default.
- W4317214248 creator A5087423546 @default.
- W4317214248 creator A5088853638 @default.
- W4317214248 date "2023-02-01" @default.
- W4317214248 modified "2023-10-18" @default.
- W4317214248 title "Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors" @default.
- W4317214248 cites W1833050134 @default.
- W4317214248 cites W1851611944 @default.
- W4317214248 cites W1965396461 @default.
- W4317214248 cites W1966414861 @default.
- W4317214248 cites W1971026321 @default.
- W4317214248 cites W1980480652 @default.
- W4317214248 cites W1983630546 @default.
- W4317214248 cites W1985476158 @default.
- W4317214248 cites W1994586297 @default.
- W4317214248 cites W1998454328 @default.
- W4317214248 cites W2032903792 @default.
- W4317214248 cites W2042680221 @default.
- W4317214248 cites W2061725286 @default.
- W4317214248 cites W2063627542 @default.
- W4317214248 cites W2066718759 @default.
- W4317214248 cites W2069499122 @default.
- W4317214248 cites W2071727203 @default.
- W4317214248 cites W2075436268 @default.
- W4317214248 cites W2081571363 @default.
- W4317214248 cites W2091801473 @default.
- W4317214248 cites W2107838011 @default.
- W4317214248 cites W2116504531 @default.
- W4317214248 cites W2138473858 @default.
- W4317214248 cites W2140050472 @default.
- W4317214248 cites W2143463421 @default.
- W4317214248 cites W2146373235 @default.
- W4317214248 cites W2151948621 @default.
- W4317214248 cites W2154010882 @default.
- W4317214248 cites W2160779087 @default.
- W4317214248 cites W2164027025 @default.
- W4317214248 cites W2212457455 @default.
- W4317214248 cites W2249076626 @default.
- W4317214248 cites W2306899626 @default.
- W4317214248 cites W2313728402 @default.
- W4317214248 cites W2326620506 @default.
- W4317214248 cites W2409321279 @default.
- W4317214248 cites W2415583146 @default.
- W4317214248 cites W2419197830 @default.
- W4317214248 cites W2471959940 @default.
- W4317214248 cites W2514594194 @default.
- W4317214248 cites W2543004764 @default.
- W4317214248 cites W2550088513 @default.
- W4317214248 cites W2551987734 @default.
- W4317214248 cites W2552944277 @default.
- W4317214248 cites W2554773181 @default.
- W4317214248 cites W2558160288 @default.
- W4317214248 cites W2560771902 @default.
- W4317214248 cites W2581301836 @default.
- W4317214248 cites W2590252333 @default.
- W4317214248 cites W2601850155 @default.
- W4317214248 cites W2606537093 @default.
- W4317214248 cites W2614842982 @default.
- W4317214248 cites W2621206827 @default.
- W4317214248 cites W2767788839 @default.
- W4317214248 cites W2768129107 @default.
- W4317214248 cites W2791923388 @default.
- W4317214248 cites W2792971737 @default.
- W4317214248 cites W2797085308 @default.
- W4317214248 cites W2800208003 @default.
- W4317214248 cites W2802760767 @default.
- W4317214248 cites W2827543800 @default.
- W4317214248 cites W2895613530 @default.
- W4317214248 cites W2901897497 @default.
- W4317214248 cites W2905629425 @default.
- W4317214248 cites W2909226523 @default.
- W4317214248 cites W2910636995 @default.
- W4317214248 cites W2917410143 @default.
- W4317214248 cites W2945601073 @default.
- W4317214248 cites W2948231191 @default.
- W4317214248 cites W2950240845 @default.
- W4317214248 cites W2955540163 @default.
- W4317214248 cites W2960190048 @default.
- W4317214248 cites W2971275989 @default.
- W4317214248 cites W2975729449 @default.
- W4317214248 cites W2990143999 @default.
- W4317214248 cites W2996784723 @default.
- W4317214248 cites W3002082014 @default.
- W4317214248 cites W3006400217 @default.
- W4317214248 cites W3012149288 @default.
- W4317214248 cites W3014306930 @default.
- W4317214248 cites W3021165068 @default.
- W4317214248 cites W3022539012 @default.
- W4317214248 cites W3035749529 @default.
- W4317214248 cites W3039444470 @default.
- W4317214248 cites W3045271478 @default.
- W4317214248 cites W3048400078 @default.